Elliott J. Mufson
Department of Neurological Sciences
Rush University Medical Center
Chicago
IL 60612
USA
Name/email consistency: high
- Hippocampal proNGF signaling pathways and β-amyloid levels in mild cognitive impairment and Alzheimer disease. Mufson, E.J., He, B., Nadeem, M., Perez, S.E., Counts, S.E., Leurgans, S., Fritz, J., Lah, J., Ginsberg, S.D., Wuu, J., Scheff, S.W. J. Neuropathol. Exp. Neurol. (2012)
- Preservation of cortical sortilin protein levels in MCI and Alzheimer's disease. Mufson, E.J., Wuu, J., Counts, S.E., Nykjaer, A. Neurosci. Lett. (2010)
- Inability of plasma and urine F2A-isoprostane levels to differentiate mild cognitive impairment from Alzheimer's disease. Mufson, E.J., Leurgans, S. Neurodegener. Dis (2010)
- Cholinergic system during the progression of Alzheimer's disease: therapeutic implications. Mufson, E.J., Counts, S.E., Perez, S.E., Ginsberg, S.D. Expert. Rev. Neurother (2008)
- Cholinotrophic molecular substrates of mild cognitive impairment in the elderly. Mufson, E.J., Counts, S.E., Fahnestock, M., Ginsberg, S.D. Curr. Alzheimer. Res (2007)
- Neuronal gene expression profiling: uncovering the molecular biology of neurodegenerative disease. Mufson, E.J., Counts, S.E., Che, S., Ginsberg, S.D. Prog. Brain Res. (2006)
- Galanin plasticity in the cholinergic basal forebrain in Alzheimer's disease and transgenic mice. Mufson, E.J., Counts, S.E., Perez, S.E., Binder, L. Neuropeptides (2005)
- Preservation of brain nerve growth factor in mild cognitive impairment and Alzheimer disease. Mufson, E.J., Ikonomovic, M.D., Styren, S.D., Counts, S.E., Wuu, J., Leurgans, S., Bennett, D.A., Cochran, E.J., DeKosky, S.T. Arch. Neurol. (2003)
- Nerve growth factor: structure, function and therapeutic implications for Alzheimer's disease. Lad, S.P., Neet, K.E., Mufson, E.J. Curr. Drug. Targets. CNS. Neurol. Disord (2003)
- Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction. Mufson, E.J., Ginsberg, S.D., Ikonomovic, M.D., DeKosky, S.T. J. Chem. Neuroanat. (2003)
- Galanin in Alzheimer disease. Counts, S.E., Perez, S.E., Ginsberg, S.D., De Lacalle, S., Mufson, E.J. Mol. Interv. (2003)
- Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. Mufson, E.J., Ma, S.Y., Dills, J., Cochran, E.J., Leurgans, S., Wuu, J., Bennett, D.A., Jaffar, S., Gilmor, M.L., Levey, A.I., Kordower, J.H. J. Comp. Neurol. (2002)
- Gene expression profiles of cholinergic nucleus basalis neurons in Alzheimer's disease. Mufson, E.J., Counts, S.E., Ginsberg, S.D. Neurochem. Res. (2002)
- Galanin receptor plasticity within the nucleus basalis in early and late Alzheimer's disease: an in vitro autoradiographic analysis. Mufson, E.J., Deecher, D.C., Basile, M., Izenwasse, S., Mash, D.C. Neuropharmacology (2000)
- Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease. Mufson, E.J., Ma, S.Y., Cochran, E.J., Bennett, D.A., Beckett, L.A., Jaffar, S., Saragovi, H.U., Kordower, J.H. J. Comp. Neurol. (2000)
- Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases. Mufson, E.J., Kroin, J.S., Sendera, T.J., Sobreviela, T. Prog. Neurobiol. (1999)
- Estrogen receptor immunoreactivity within subregions of the rat forebrain: neuronal distribution and association with perikarya containing choline acetyltransferase. Mufson, E.J., Cai, W.J., Jaffar, S., Chen, E., Stebbins, G., Sendera, T., Kordower, J.H. Brain Res. (1999)
- m2 muscarinic acetylcholine receptor-immunoreactive neurons are not reduced within the nucleus basalis in Alzheimer's disease: relationship with cholinergic and galaninergic perikarya. Mufson, E.J., Jaffar, S., Levey, A.I. J. Comp. Neurol. (1998)
- Galanin expression within the basal forebrain in Alzheimer's disease. Comments on therapeutic potential. Mufson, E.J., Kahl, U., Bowser, R., Mash, D.C., Kordower, J.H., Deecher, D.C. Ann. N. Y. Acad. Sci. (1998)
